A Study of LIV001 in Healthy Subjects and Those With Mild-to-Moderate Active Ulcerative Colitis (UC)
Status:
Recruiting
Trial end date:
2024-07-30
Target enrollment:
Participant gender:
Summary
This study is only for the first in human phase 1a study designed to investigate the safety
and tolerability of LIV001 in healthy participants. LIV001 will be investigated for the
safety and efficacy in participants with Ulcerative Colitis (UC) in a phase 1b study.